Gyre Therapeutics (GYRE) Debt Ratio (2010 - 2014)

Gyre Therapeutics (GYRE) posted quarterly Debt Ratio of 0.0 for Q3 2014, down 51.91% year-over-year from 0.01 in Q3 2013, and down 26.67% quarter-over-quarter from 0.01 in Q2 2014.

Gyre Therapeutics (GYRE) Debt Ratio (2010 - 2014) Analysis & Trends

Gyre Therapeutics (GYRE) has reported Debt Ratio for 5 consecutive years, with 0.0 the latest figure, recorded in Q3 2014.

  • In Q3 2014, Debt Ratio fell 51.91% year-over-year to 0.0; the TTM figure through Sep 2014 stood at 0.0 (down 51.91% YoY), while the FY2013 annual figure was 0.01, down 25.7% from the prior year.
  • Debt Ratio eased to 0.0 in Q3 2014 per GYRE's latest filing, from 0.01 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.01 in Q2 2011 and bottomed at 0.0 in Q3 2014.
  • Historically, Debt Ratio has averaged 0.01 across 5 years, with a median of 0.01 in 2012.
  • Annual changes were most pronounced in 2011 — Debt Ratio gained 7.4% — and 2014, when it plunged 51.91%.
  • Gyre Therapeutics' Debt Ratio stood at 0.01 in 2010, then grew by 7.4% to 0.01 in 2011, then slipped by 16.16% to 0.01 in 2012, then dropped by 25.7% to 0.01 in 2013, then plunged by 47.14% to 0.0 in 2014.
  • Business Quant data shows GYRE's Debt Ratio at 0.0 in Q3 2014, 0.01 in Q2 2014, and 0.01 in Q1 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 Gyre Therapeutics 708.31 Mn 685.47 Mn 26.90 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2014 0.00
Jun 30, 2014 0.01
Mar 31, 2014 0.01
Dec 31, 2013 0.01
Sep 30, 2013 0.01
Jun 30, 2013 0.01
Mar 31, 2013 0.01
Dec 31, 2012 0.01
Sep 30, 2012 0.01
Jun 30, 2012 0.01
Mar 31, 2012 0.01
Dec 31, 2011 0.01
Sep 30, 2011 0.01
Jun 30, 2011 0.01
Dec 31, 2010 0.01